miércoles, 30 de mayo de 2012

NCI's Advanced Technology Research Facility Opens ► NCI Cancer Bulletin for May 29, 2012 - National Cancer Institute

NCI Cancer Bulletin for May 29, 2012 - National Cancer Institute


NCI's Advanced Technology Research Facility Opens

NCI's Advanced Technology Research Facility in Frederick, MD NCI's Advanced Technology Research Facility in Frederick, MD


On May 21, more than 700 guests attended a ribbon-cutting ceremony to mark the opening of NCI's Advanced Technology Research Facility (ATRF) in Frederick, MD. NCI's Deputy Director for Management John Czajkowski, SAIC President and CEO John Jumper, SAIC-Frederick CEO David Heimbrook, and Rep. Roscoe Bartlett (R-MD) joined representatives of the Frederick County Chamber of Commerce at the ceremony.

The event, hosted by the Chamber, was held in the three-story open atrium of the 330,000-square-foot research and development facility that will house staff from the Frederick National Laboratory for Cancer Research. The ATRF includes laboratories for studying genetics, genomics, proteomics, advanced biomedical imaging, nanotechnology, and clinical-grade drug development and manufacturing for first-in-human studies.

The facility will be a centerpiece of NCI's efforts to develop partnerships that bring together collaborators from government, industry, academia, and the nonprofit sector. These efforts can accelerate the translation of basic research findings into clinical technologies, diagnostics, and treatments for patients with cancer and AIDS. About 40,000 square feet of the interior space will be reserved for partnership projects and start-up companies coming out of the projects.

"This building is designed to facilitate collaboration," said Dr. Heimbrook, in his opening remarks. "Within a few short months, these hallways will be filled with scientists from NCI, SAIC-Frederick, and our partners, doing research and development work to further NCI's mission to provide new hope to patients afflicted with cancer and AIDS."

The work done at the ATRF will pave the way for doctors to "provide the right drug, to the right patient, at the right time," he added.

No hay comentarios:

Publicar un comentario